References
- Wu S, Kocherginsky M, Hibbard JU. Abnormal placentation: twenty-year analysis. Am J Obstet Gynecol. 2005;192(5):1458–1461.
- Jauniaux E, Hussein AM, Fox KA, et al. New evidence-based diagnostic and management strategies for placenta accreta spectrum disorders. Best Pract Res Clin Obstet Gynaecol. 2019;61:75–88.
- Sentilhes L, Kayem G, Silver RM. Conservative management of placenta accreta spectrum. Clin Obstet Gynecol. 2018;61(4):783–794.
- Society of Gynecologic Oncology; American College of Obstetricians and Gynecologists and the Society for Maternal–Fetal Medicine; Cahill AG, et al. Placenta accreta spectrum. Am J Obstet Gynecol. 2018;219(6):B2–B16.
- Legendre G, Zoulovits FJ, Kinn J, et al. Conservative management of placenta accreta: hysteroscopic resection of retained tissues. J Minim Invasive Gynecol. 2014;21(5):910–913.
- Ye M, Yin Z, Xue M, et al. High-intensity focused ultrasound combined with hysteroscopic resection for the treatment of placenta accreta. BJOG. 2017;124 Suppl 3:71–77.
- Bai Y, Luo X, Li Q, et al. High-intensity focused ultrasound treatment of placenta accreta after vaginal delivery: a preliminary study. Ultrasound Obstet Gynecol. 2016;47(4):492–498.
- The American Fertility Society classifications of adnexal adhesions, distal tubal occlusion, tubal occlusion secondary to tubal ligation, tubal pregnancies, mullerian anomalies and intrauterine adhesions. Fertil Steril. 1988;49(6):944–955.
- Eller AG, Porter TF, Soisson P, et al. Optimal management strategies for placenta accreta. BJOG. 2009;116(5):648–654.
- Sentilhes L, Kayem G, Ambroselli C, et al. Fertility and pregnancy outcomes following conservative treatment for placenta accreta. Hum Reprod. 2010;25(11):2803–2810.
- Silver RM, Branch DW. Placenta accreta spectrum. N Engl J Med. 2018;378(16):1529–1536.
- Steins Bisschop CN, Schaap TP, Vogelvang TE, et al. Invasive placentation and uterus preserving treatment modalities: a systematic review. Arch Gynecol Obstet. 2011;284(2):491–502.
- Takeda A, Koike W. Conservative endovascular management of retained placenta accreta with marked vascularity after abortion or delivery. Arch Gynecol Obstet. 2017;296(6):1189–1198.
- Zhang L, Zhang W, Orsi F, et al. Ultrasound-guided high intensity focused ultrasound for the treatment of gynaecological diseases: a review of safety and efficacy. Int J Hyperthermia. 2015;31(3):280–284.
- Haiyan S, Lin W, Shuhua H, et al. High-intensity focused ultrasound (HIFU) combined with gonadotropin-releasing hormone analogs (GnRHa) and levonorgestrel-releasing intrauterine system (LNG-IUS) for adenomyosis: a case series with long-term follow up. Int J Hyperthermia. 2019;36(1):1179–1185.
- Huang L, Du Y, Zhao C. High-intensity focused ultrasound combined with dilatation and curettage for Cesarean scar pregnancy. Ultrasound Obstet Gynecol. 2014;43(1):98–101.
- Golan A, Dishi M, Shalev A, et al. Operative hysteroscopy to remove retained products of conception: novel treatment of an old problem. J Minim Invasive Gynecol. 2011;18(1):100–103.